Royal Bank Of Canada Orgenesis Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.39 - $0.63 $140 - $227	361 Added 347.12%	465 $0
Q1 2024 Nov 05, 2024	SELL	$0.28 - $0.9 $101 - $324	-361 Reduced 77.63%	104 $0
Q1 2024 May 15, 2024	BUY	$0.28 - $0.9 $29 - $93	104 New	104 $0
Q3 2023 Nov 14, 2023	SELL	$0.41 - $1.4 $68 - $232	-166 Reduced 58.66%	117 $0
Q2 2023 Aug 14, 2023	BUY	$1.01 - $1.44 $285 - $407	283 New	283 $0
Q3 2022 Nov 14, 2022	BUY	$1.38 - $2.38 $227 - $392	165 New	165 $0
Q3 2021 Nov 15, 2021	SELL	$4.6 - $5.44 $26,114 - $30,882	-5,677 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.19 - $5.88 $23,786 - $33,380	5,677 New	5,677 $29,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.